Hiroki Nagase, Shuichi Takagahara, Yoshinori Satomi, Ayumi Ando, Kazuki Kubo, & Shota Ikeda. (2021). Effects of compound-326, a selective delta-5 desaturase inhibitor, in ApoE knockout mice with two different protocols for atherosclerosis development. Frontiers Media S.A..
Chicago Style (17th ed.) CitationHiroki Nagase, Shuichi Takagahara, Yoshinori Satomi, Ayumi Ando, Kazuki Kubo, and Shota Ikeda. Effects of Compound-326, a Selective Delta-5 Desaturase Inhibitor, in ApoE Knockout Mice with Two Different Protocols for Atherosclerosis Development. Frontiers Media S.A., 2021.
MLA (9th ed.) CitationHiroki Nagase, et al. Effects of Compound-326, a Selective Delta-5 Desaturase Inhibitor, in ApoE Knockout Mice with Two Different Protocols for Atherosclerosis Development. Frontiers Media S.A., 2021.